These are the foods to avoid at Thanksgiving if you're taking GLP-1 meds
Weight-loss drug users should avoid heavy foods like mac and cheese and candied yams on Thanksgiving, focusing instead on moderation and lighter options.
The New York Times Presents: Weight of the World' on Ozempic's Rise
The documentary 'Weight of the World' explores the impact of GLP-1 medications on modern weight loss culture and societal views on body image.
5 new weight-loss drugs to watch in the fight for the next Ozempic
GLP-1 medications revolutionize healthcare, but new formulations promise even greater effectiveness and convenience for weight loss and diabetes management.
These are the foods to avoid at Thanksgiving if you're taking GLP-1 meds
Weight-loss drug users should avoid heavy foods like mac and cheese and candied yams on Thanksgiving, focusing instead on moderation and lighter options.
The New York Times Presents: Weight of the World' on Ozempic's Rise
The documentary 'Weight of the World' explores the impact of GLP-1 medications on modern weight loss culture and societal views on body image.
5 new weight-loss drugs to watch in the fight for the next Ozempic
GLP-1 medications revolutionize healthcare, but new formulations promise even greater effectiveness and convenience for weight loss and diabetes management.
'It gives MLM vibes': Inside the Ozempic influencer marketing model
Influencers face ethical dilemmas when promoting medically sensitive products like GLP-1 medications.
Increased demand for weight-loss medications has led to significant influencer marketing offers.
There is a rise in online sales of GLP-1 medications, yet regulation is lacking.
Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds
Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
More People Are Overdosing on Ozempic Alternatives
Patients are experiencing serious risks by overdosing on compounded GLP-1 medications, spurred by demand for cheaper alternatives and availability issues of brand-name products.
This $2 billion unicorn startup is corporate America's secret weapon against Ozempic
As more people seek coverage for GLP-1 medications, employers are halting coverage due to rising costs.
Virta offers a cheaper alternative to GLP-1s through its virtual platform and nutritional therapy to reverse type 2 diabetes and obesity.
Ozempic's popularity leads to shortages for people with Type 2 diabetes
Patients with Type 2 diabetes face drug shortages for GLP-1 medications like Trulicity, Ozempic, and Mounjaro, impacting health and treatment.
A telehealth company created a tool to report drug shortages and help patients locate available GLP-1 drugs within 100 miles of their location.